ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
HORIZON KINETICS MEDICAL ETF
34.99
+0.0328
0.09%
盤後:
34.99
0.0000
0.00%
16:10 EDT
成交量:
428
成交額:
1.51萬
市值:
1,644.36萬
市盈率:
- -
高:
35.11
開:
35.11
低:
34.99
收:
34.96
52周最高:
37.90
52周最低:
28.87
股本:
46.99萬
流通股本:
46.99萬
量比:
0.32
換手率:
0.09%
股息:
0.41
股息率:
1.17%
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
三重動力支撐創新藥企「強者更強」
证券日报
·
4小時前
諾華製藥(NVS.US):VHB937未達到其主要終點和次要終點。根據2期ASTRALS研究結果,已停止VHB937用於
格隆汇
·
昨天
諾華宣佈終止ALS藥物VHB937的研發。
智通财经
·
昨天
強生:鋭珂捷®埃萬妥單抗注射液在中國上市
智通财经
·
昨天
Circle Pharma融資新動態:Column Group領投,禮來戰略入股
美股速递
·
昨天
安圖生物高敏HIV-1核酸檢測試劑盒獲醫療器械註冊證
智通财经
·
昨天
新產業:公司全自動核酸檢測分析系統獲得醫療器械註冊證
智通财经
·
昨天
戴維醫療:醫療器械生產許可證新增兩類Ⅲ類生產範圍
智通财经
·
昨天
內蒙古烏蘭察布市市場監管局紮實推進醫療器械抽檢工作
中国质量新闻网
·
昨天
新加坡醫療服務提供商LYC Healthcare IPO定價4美元/股 籌資規模上調67%至2500萬美元
中金财经
·
昨天
新加坡醫療服務提供商LYC Healthcare IPO定價4美元/股 籌資規模上調67%至2500萬美元
智通财经
·
昨天
新加坡醫療服務提供商LYC Healthcare IPO定價4美元/股 籌資規模上調67%至2500萬美元
智通财经
·
昨天
創新藥概念股表現活躍
智通财经
·
昨天
香港:建設國際藥械權威監管機構 建立自主藥械審評能力
智通财经
·
昨天
江小涓:這個數據大家不要吃驚,未來幾年還要漲
凤凰网港股
·
昨天
創新藥概念局部走強 恒瑞醫藥(01276)漲2.74% 機構料企業扭虧節點到來
金吾财讯
·
昨天
諾華前高管張穎出任傳奇生物CEO,老東家卻正值「多事之秋」
每日经济新闻
·
昨天
我國將首次制定全國統一的醫保醫療服務項目目錄 進一步規範醫保支付範圍
金吾财讯
·
昨天
國家醫保局出台方案 啓動首批全國統一醫保醫療服務項目目錄編制
格隆汇
·
昨天
中國生物製藥:本集團附屬公司正大天晴藥業集團股份有限公司自主研發的國家 1 類創新藥 TQB2102 注射液「HER2
智通财经
·
昨天
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/MEDX/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MEDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","market":"US","secType":"STK","nameCN":"HORIZON KINETICS MEDICAL ETF","latestPrice":34.9905,"timestamp":1789588800000,"preClose":34.9577,"halted":0,"volume":428,"hourTrading":{"tag":"盘后","latestPrice":34.9905,"preClose":34.9905,"latestTime":"16:10 EDT","volume":6,"amount":209.94299999999998,"timestamp":1789589404311,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0009382768317136027,"floatShares":469946,"shares":469946,"eps":0,"marketStatus":"盤後交易","change":0.0328,"latestTime":"09-16 16:34:30 EDT","open":35.105,"high":35.105,"low":34.9905,"amount":15054,"amplitude":0.003275,"askPrice":37,"askSize":35,"bidPrice":34.05,"bidSize":15,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":34.9577,"sharesOutstanding":569946,"nav":35.26,"aum":16570295.96,"dividendRate":0.011689,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.9905,"preClose":34.9905,"latestTime":"16:10 EDT","volume":6,"amount":209.94299999999998,"timestamp":1789589404311,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.317037},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","floatShares":469946,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.317037,"shares":469946,"dividePrice":0.409,"high":35.105,"amplitude":0.003275,"preClose":34.9577,"low":34.9905,"week52Low":28.8652,"pbRate":"--","week52High":37.9,"institutionHeld":0,"latestPrice":34.9905,"committee":-0.4,"eps":0,"divideRate":0.011689,"volume":428,"delay":0,"ttmEps":0,"open":35.105,"prevYearClose":33.2024,"prevWeekClose":34.9572,"prevMonthClose":36.417,"prevQuarterClose":36.7138,"fiveDayClose":35.2396,"twentyDayClose":36.4884,"sixtyDayClose":34.3915},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDX\",params:#limit:5,,,undefined,":[{"date":"2025-12-23","symbol":"MEDX","amount":0.4088,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2024-12-24","symbol":"MEDX","amount":0.502335,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"MEDX","amount":1.379798,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"HORIZON KINETICS MEDICAL ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":1.379798,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.502335,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-24","value":0.4088,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668987804","title":"三重動力支撐創新藥企「強者更強」","url":"https://stock-news.laohu8.com/highlight/detail?id=2668987804","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668987804?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 00:01","pubTimestamp":1789574460,"startTime":"0","endTime":"0","summary":"今年以来,创新药行业分化愈发明显。招商证券统计显示,91家A/H股创新药公司中,2026年上半年共有44家实现盈利,其中盈利额前五的公司占全部盈利公司利润总额的48%。中国创新药跨境BD(商务拓展)同样呈现集中趋势。据动脉智库数据,2026年上半年,中国创新药对外BD的潜在总额达1100亿美元,其中,交易金额体量排名前十的项目的总金额为739.14亿美元,占比在六成以上。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609173876437951.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609173876437951.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IBBQ","MEDX","159992","BK1161","LNGR","BK1574","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667898420","title":"諾華製藥(NVS.US):VHB937未達到其主要終點和次要終點。根據2期ASTRALS研究結果,已停止VHB937用於","url":"https://stock-news.laohu8.com/highlight/detail?id=2667898420","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667898420?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 23:39","pubTimestamp":1789573152,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4585","PPH","LU0211331839.USD","IE0002141913.USD","BK4007","LU0320765489.SGD","IE00BFTCPJ56.SGD","BK4578","BK4588","BK4532","NVS","LU0208291251.USD","MEDX","IE00B4R5TH58.HKD","LU0070302665.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667898585","title":"諾華宣佈終止ALS藥物VHB937的研發。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667898585","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667898585?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:43","pubTimestamp":1789562627,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B2B36J28.USD","PPH","BK4585","IE0009355771.USD","MEDX","LU0070302665.USD","IE00BJJMRZ35.SGD","BK4578","BK4007","LU0208291251.USD","LU0320765489.SGD","BK4588","IE00BJT1NW94.SGD","NVS","IE0002141913.USD","BK4532","LU0211331839.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667885079","title":"強生:鋭珂捷®埃萬妥單抗注射液在中國上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2667885079","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667885079?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 19:49","pubTimestamp":1789559357,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BFTCPJ56.SGD","IPOS","LU1162221912.USD","SGXZ57979304.SGD","LU0943347566.SGD","LU0122379950.USD","LU0689472784.USD","IE00B2B36J28.USD","FHLC","BK4585","LU0738911758.USD","JDOC","IE0034235303.USD","IE00B1BXHZ80.USD","LU2403377893.USD","LU0345769128.USD","IYH","LU0098860793.USD","LU1280957306.USD","LU1196500208.SGD","BMED","FTXH","XLV","LU1894683348.USD","VHT","LU1061106388.HKD","LU0345770308.USD","LU1043141123.HKD","BK4532","IHE","IE000SO60NU8.SGD","LU2756315318.SGD","LU2417539215.USD","LU0162691827.USD","LU1074936037.SGD","GDOC","TRUH","IXJ","MEDX","LU0426412945.USD","LU1718418525.SGD","LU0795875086.SGD","JNJ","LU0426417589.USD","IE00B4R5TH58.HKD","LU0203345920.USD","PJP","BK4581","SG9999001440.SGD","RXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149338058","title":"Circle Pharma融資新動態:Column Group領投,禮來戰略入股","url":"https://stock-news.laohu8.com/highlight/detail?id=1149338058","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149338058?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 19:06","pubTimestamp":1789556772,"startTime":"0","endTime":"0","summary":"Circle Pharma近日宣布完成新一轮融资。此轮融资由Column Group领投,Nextech Invest与Ra Capital Management共同参与。值得注意的是,礼来公司也以战略投资者的身份加入其中。多方资本汇聚,既体现了投资界对Circle Pharma前景的认可,也凸显了制药巨头礼来在创新疗法领域的布局意图。从投资方结构来看,既有深耕生物医药的专业风投,也有全球领先的药企巨头,这种组合往往意味着更深层的战略协同可能性。Circle Pharma的研发管线或将成为这些资本力量交汇的焦点所在。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0198837287.USD","LU2237443465.HKD","IE00BFTCPJ56.SGD","LU0820562030.AUD","LU1267930730.SGD","LU1989771016.USD","LU2360106947.USD","LU2028103732.USD","LU0882574139.USD","LU0385154629.USD","BK4588","IE0005OL40V9.USD","SG9999014898.SGD","LU0820561818.USD","LU1548497426.USD","LU2461242641.AUD","GDOC","LU0471298694.HKD","LU0471298777.SGD","LU2361044865.SGD","LU0238689110.USD","LU1983299246.USD","LU2491049909.HKD","LU2552382058.USD","CURE","BK4534","LU0174119429.USD","LU2361045086.USD","TMED","LU1064131342.USD","BK4516","BK4007","LU2456880835.USD","LU1814569148.SGD","LU2602419157.SGD","LU1323610961.USD","MEDX","LU2471134952.CNY","IE00BFSS8Q28.SGD","LU2089984988.USD","SG9999014880.SGD","LU2111349929.HKD","MEDI","LU0094547139.USD","LU0323591593.USD","LU2746668974.SGD","OZEM","SG9999017495.SGD","LU1145028129.USD","LU2112291526.USD","LU0320765992.SGD","LU2324357040.USD","BK4599","LU1720051017.SGD","LU2417539215.USD","LU2237438978.USD","LU0708995401.HKD","SG9999001176.USD","IE00BJJMRY28.SGD","AGNG","LU2237443622.USD","LU2750360997.AUD","PPH","SG9999018857.SGD","IE00B775H168.HKD","LU0210536198.USD","SG9999013999.USD","LU0882574055.USD","LU2264538146.SGD","VHT","FTXH","SGXZ57979304.SGD","LU0106261372.USD","LU0820561909.HKD","LU0133085943.USD","LU0158827948.USD","LU1551013342.USD","IE0001KFT4U8.USD","LU0320765059.SGD","LU0096364046.USD","LU1127390331.HKD","LU2089283258.USD","LU2756315664.SGD","LU1629891620.HKD","LU2237443978.SGD","LU0061475181.USD","LU2552382132.HKD","LU0786609619.USD","LU2106854487.HKD","IE00BFSS7M15.SGD","LU1093756168.USD","LU0353189680.USD","LU0889565916.HKD","IE00B2B36J28.USD","GB00BDT5M118.USD","LU2023250504.SGD","LU2491050071.SGD","IE00BJJMRZ35.SGD","LU1551013425.SGD","RXL","LU2357305700.SGD","IE00BWXC8680.SGD","LU1280957306.USD","LLY","LU0354030511.USD","XLV","IE0002141913.USD","LU0109394709.USD","LU0006306889.USD","MHIP","LU1868836914.USD","IE00BJLML261.HKD","IE00BKPKM429.USD","WDNA","LU2087625088.SGD","IE0004445015.USD","SGXZ31699556.SGD","IE00B7KXQ091.USD","LU1291159041.SGD","LU1691799644.USD","LU1974910355.USD","LU1979441026.SGD","ILDR","SG9999018865.SGD","LU1023059063.AUD","SG9999015945.SGD","LU1093756325.SGD","LU2168563687.JPY","LU2462591350.SGD","LU0266013472.USD","LU2063271972.USD","LU0289739699.SGD","LU0345770993.USD","LU2265009873.SGD","IE00BKDWB100.SGD","LLYZ","ELIS","LU2462157665.USD","HRTS","SG9999014914.USD","LU0203202063.USD","BK4581","LU0354030438.USD","LU0640476718.USD","IE00B4JS1V06.HKD","LU2756315318.SGD","LU1988902786.USD","SG9999015952.SGD","LU2552382215.SGD","LU0203201768.USD","LU0823434740.USD","LU1061106388.HKD","LU1917777945.USD","LU1868836757.USD","IE00BJJMRX11.SGD","LU2236285917.USD","LU2168564065.EUR","LU0964807845.USD","LU0079474960.USD","LU0234572021.USD","LU0787776722.HKD","LU1720051108.HKD","IE00BN29S564.USD","FHLC","TRUH","LU2211815571.USD","LU0689472784.USD","LU0316494557.USD","LU2471134523.USD","SG9999015978.USD","LU2023251221.USD","LU0114720955.EUR","LU2896262040.SGD","LU1868837300.USD","IE00B4R5TH58.HKD","LU0097036916.USD","LU2237443382.USD","SG9999001176.SGD","THNR","IE00BJT1NW94.SGD","IE00BK4W5L77.USD","IYH","LU0456855351.SGD","IE00B1BXHZ80.USD","SGXZ99366536.SGD","LU0683600562.USD","LU2213496289.HKD","LU2471134879.HKD","IHE","IE0009355771.USD","LU0109391861.USD","LU0158827781.USD","BK4533","LU0345770308.USD","CANC","LU0943347566.SGD","LU1232071149.USD","LU1366192091.USD","IE00BK4W5M84.HKD","LU1712237335.SGD","LLII","SG9999015986.USD","SGXZ51526630.SGD","LU0122379950.USD","LU1804176565.USD","BK4585","LU2089284900.SGD","LU1057294990.SGD","LU2491050154.USD","JDOC","LLYX","IE0004445239.USD","LU1035775433.USD","LU2471134796.USD","LU2468319806.SGD","LU2746668461.USD","SG9999014906.USD","SGXZ81514606.USD","LU2750360641.GBP","LU0256863902.USD","LU0225283273.USD","PJP","LU1623119135.USD","LU2108987350.USD","LU2168564222.USD","ELIL","LU0432979614.USD","LU0823416689.USD","LU1868837136.USD","LU2271345857.HKD","LU0466842654.USD","LU0256863811.USD","LU2023250330.USD","LU0058720904.USD","LU2361044949.HKD","IXJ","LU0823434583.USD","LU2168564495.EUR","LU2237443895.HKD","LU1069344957.HKD","LU2168564149.EUR","LU0417517546.SGD","LU0672654240.SGD","LU1868836591.USD","IE00B1XK9C88.USD","LU2237443549.SGD","LU0353189763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667601077","title":"安圖生物高敏HIV-1核酸檢測試劑盒獲醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2667601077","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667601077?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 17:42","pubTimestamp":1789551752,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RSPH","MEDX","PTH","HART","LNGR","MDEV","AGNG","GDOC","IEIH","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667606258","title":"新產業:公司全自動核酸檢測分析系統獲得醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2667606258","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667606258?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 16:39","pubTimestamp":1789547975,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGNG","GDOC","LNGR","MEDX","PTH","IEIH","HART","LGHT","MDEV","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667605655","title":"戴維醫療:醫療器械生產許可證新增兩類Ⅲ類生產範圍","url":"https://stock-news.laohu8.com/highlight/detail?id=2667605655","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667605655?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 15:58","pubTimestamp":1789545498,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","MDEV","AGNG","IEIH","PTH","RSPH","GDOC","HART","LNGR","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667037996","title":"內蒙古烏蘭察布市市場監管局紮實推進醫療器械抽檢工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2667037996","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667037996?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 15:32","pubTimestamp":1789543920,"startTime":"0","endTime":"0","summary":"中国质量新闻网讯 2026年,内蒙古乌兰察布市市场监管局紧扣自治区抽检工作部署,扎实推进医疗器械抽检工作。紧扣自治区部署,对往年国抽不合格品种及区内严重伤害报告数较多品种优先安排、重点保障,确保高风险品种抽检任务足量完成。下一步,乌兰察布市市场监管局将提前摸排库存底数、强化人员培训、严格核查处置,切实守好群众用械安全底线。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-16/doc-inirzfsy2892323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LGHT","BK1583","HART","MEDX","RSPH","AGNG","09996","GDOC","IEIH","LNGR","MDEV","BK1574","PTH","159883","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667158608","title":"新加坡醫療服務提供商LYC Healthcare IPO定價4美元/股 籌資規模上調67%至2500萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667158608","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667158608?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 14:57","pubTimestamp":1789541822,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,在新加坡运营医疗诊所和骨科手术中心的LYC Healthcare于周二提高了即将进行的首次公开募股的拟议发行规模。该公司目前计划发行630万股股票,拟议发行价为每股4美元,以筹集2500万美元。此前,公司已提交文件,计划发行300万股,发行价区间为每股4至6美元。按照调整后的发行规模,LYC Healthcare预计募资金额将较此前预期高出67%,对应市值将达到1.37亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260916/32371585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["UUP","BK4585","LABU","XLV","STmain","UDN","BK4581","MEDX","XBI","IPOS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667670478","title":"新加坡醫療服務提供商LYC Healthcare IPO定價4美元/股 籌資規模上調67%至2500萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667670478","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667670478?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 14:28","pubTimestamp":1789540088,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,在新加坡运营医疗诊所和骨科手术中心的LYC Healthcare于周二提高了即将进行的首次公开募股的拟议发行规模。按照调整后的发行规模,LYC Healthcare预计募资金额将较此前预期高出67%,对应市值将达到1.37亿美元。LYC Healthcare成立于2017年,是一家位于新加坡的多学科专科医疗服务提供商,通过两家运营子公司、5家医疗诊所以及内部先进影像设施,提供一体化的肌肉骨骼医疗服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496725.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4581","IPOS","UUP","MEDX","BK4585","BK4588","XBI","STmain","LABU","UDN","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667670424","title":"新加坡醫療服務提供商LYC Healthcare IPO定價4美元/股 籌資規模上調67%至2500萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667670424","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667670424?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 14:28","pubTimestamp":1789540088,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","IPOS","XLV","BK4585","BK4581","UDN","BK4588","XBI","UUP","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667724676","title":"創新藥概念股表現活躍","url":"https://stock-news.laohu8.com/highlight/detail?id=2667724676","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667724676?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 13:18","pubTimestamp":1789535894,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","MEDX","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667567483","title":"香港:建設國際藥械權威監管機構 建立自主藥械審評能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2667567483","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667567483?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 11:47","pubTimestamp":1789530430,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LNGR","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667674545","title":"江小涓:這個數據大家不要吃驚,未來幾年還要漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2667674545","media":"凤凰网港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667674545?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 11:44","pubTimestamp":1789530285,"startTime":"0","endTime":"0","summary":"江小涓表示,我国创新药产业正迎来全球化爆发新阶段,产业规模与国际影响力持续攀升。江小涓解释,依托AI平台找到治病靶点、匹配新化合物,我国拥有了新药青苗,成果本身很好,但还只是一棵青苗,还需要把好苗对外授权进行进一步培育和商业化。江小涓进一步解释,AI会使产业链出现一些变化。江小涓说,“所以AI for Science不仅仅是我们把自己做好,还会引起全球产业链非常快速的调整,这些行业都是如此,这是一个非常大的变化。”","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://original.ifeng.com/c/8wSeX6t1BpL","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTY","VTHR","AIPO","CHAT","IBBQ","BK1161","MEDX","QTOC","LNGR","AGIX","06978","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667617679","title":"創新藥概念局部走強 恒瑞醫藥(01276)漲2.74% 機構料企業扭虧節點到來","url":"https://stock-news.laohu8.com/highlight/detail?id=2667617679","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667617679?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 10:20","pubTimestamp":1789525259,"startTime":"0","endTime":"0","summary":"消息面上,国金证券表示,创新药企业扭亏节点到来,全年临床数据催化密集,叠加已BD出海管线海外临床进展顺利,看好创新药板块投资机会。诚通证券表示,2025年为创新药海外授权BD大年,2026H1我国创新药海外授权BD交易继续大幅增长,总交易金额已接近1000亿美元,国产创新药已从偶发性出海转变为系统性趋势。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/NTQxOTRlZTU5ZGZkZjc4MmEzMTdjMTVhMTM1NjYxOTg3NzU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NTQxOTRlZTU5ZGZkZjc4MmEzMTdjMTVhMTM1NjYxOTg3NzU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991724","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516423174.USD","LU0348827113.USD","LNGR","LU2148510915.USD","LU1328615791.USD","LU0043850808.USD","09688","BK0060","01477","159992","LU0307460666.USD","01177","06978","LU0359201612.USD","LU1655091616.SGD","BK1574","LU1255011170.USD","BK1515","LU0456846285.SGD","LU0516422952.EUR","KURE","LU2097828557.USD","LU0327786744.USD","LU0417516902.SGD","LU1023057109.AUD","MEDX","IE00BZ08YS42.EUR","IE00B0JY6N72.USD","LU0405327148.USD","LU2039709279.SGD","LU0588546209.SGD","LU2097828805.USD","600276","LU0140636845.USD","LU0128526141.USD","02269","LU0561508036.HKD","LU2580892789.USD","LU1820825898.SGD","LU1997244956.HKD","BK0188","BK0183","LU2488822045.USD","LU1146622755.USD","LU1580142542.USD","01276","LU0348825331.USD","IBBQ","02637","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667675210","title":"諾華前高管張穎出任傳奇生物CEO,老東家卻正值「多事之秋」","url":"https://stock-news.laohu8.com/highlight/detail?id=2667675210","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667675210?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 09:15","pubTimestamp":1789521317,"startTime":"0","endTime":"0","summary":"9月15日,CAR-T细胞疗法企业传奇生物(LEGN)宣布,董事会已任命张颖为首席执行官(CEO),自2026年9月15日起生效。张颖将接替自2026年7月起出任临时首席执行官的AlanBash,后者将继续担任CARVYKTI业务总裁。在加入传奇生物前,张颖曾在诺华任职超过15年,并担任过诺华中国区总裁兼董事总经理。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609163875615778.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609163875615778.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE0009355771.USD","IE00B4R5TH58.HKD","BK4585","MEDX","LEGN","BK4139","BK4588","IE00B2B36J28.USD","BK4578","LU0070302665.USD","MEDI","LU0320765489.SGD","NVS","MEMS","IE00BJT1NW94.SGD","BK4532","BK4505","IE00BFTCPJ56.SGD","BK4007","LU0211331839.USD","PPH","IE0002141913.USD","CANC","IE00BJJMRZ35.SGD","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667755546","title":"我國將首次制定全國統一的醫保醫療服務項目目錄 進一步規範醫保支付範圍","url":"https://stock-news.laohu8.com/highlight/detail?id=2667755546","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667755546?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 09:04","pubTimestamp":1789520689,"startTime":"0","endTime":"0","summary":"目录落地后,将率先应用于跨省异地就医结算,再逐步和各省支付范围衔接。此举将推动医保支付更加规范高效,更好守护群众看病就医权益。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250106/MzdhOTliMTI0NzhlMTgxMzU2MzczNzM1NA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/MzdhOTliMTI0NzhlMTgxMzU2MzczNzM1NA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991707","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667626673","title":"國家醫保局出台方案 啓動首批全國統一醫保醫療服務項目目錄編制","url":"https://stock-news.laohu8.com/highlight/detail?id=2667626673","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667626673?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 08:43","pubTimestamp":1789519394,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667530620","title":"中國生物製藥:本集團附屬公司正大天晴藥業集團股份有限公司自主研發的國家 1 類創新藥 TQB2102 注射液「HER2","url":"https://stock-news.laohu8.com/highlight/detail?id=2667530620","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667530620?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 07:10","pubTimestamp":1789513851,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LNGR","IBBQ","MEDX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":1,"totalSize":254,"code":"91000000","status":"200"}]}}